Page 52 - 《中国药房》2023年7期
P. 52

壮药痛风立安胶囊对痛风性关节炎的抗炎作用及机制研究
                                                                                                    Δ


                *
          赵湘培 ,杜娜娜,李凤珍,舒建龙,龙朝阳,邹晓素,孙宗喜(广西中医药大学附属国际壮医医院壮瑶医药研究
                                                               #
          实验室,南宁 530201)

          中图分类号  R965      文献标志码  A      文章编号  1001-0408(2023)07-0814-05
          DOI  10.6039/j.issn.1001-0408.2023.07.09


          摘   要  目的  结合体内外实验研究壮药痛风立安胶囊对痛风性关节炎的抗炎作用及机制。方法  将60只大鼠随机分为正常组、
          模型组、阳性对照组(27 mg/kg别嘌醇+0.27 mg/kg秋水仙碱)和痛风立安胶囊低、中、高剂量组(2.2、4.5、9.0 g/kg),每组10只。除
          正常组外,其余各组大鼠均诱导痛风性关节炎模型。各给药组大鼠灌胃相应药物,正常组和模型组大鼠灌胃等体积纯水,连续14
          d。检测大鼠踝关节肿胀率、血清中白细胞介素1β(IL-1β)水平、滑膜组织中核因子κB(NF-κB)蛋白表达水平,观察大鼠踝关节滑
          膜组织病理形态学变化。另以脂多糖刺激RAW264.7细胞建立炎症模型,以痛风立安胶囊(62.5、125、250 μg/mL)干预后,检测细
          胞中一氧化氮(NO)、活性氧(ROS)、IL-1β水平,NF-κB蛋白表达水平及其在细胞内的定位。结果  体内实验结果显示,与正常组
          比较,模型组大鼠踝关节肿胀率、血清中IL-1β水平、滑膜组织中NF-κB蛋白表达水平均显著升高(P<0.05),表现出滑膜增生、水
          肿、血管充血、毛细血管增生、炎症细胞增多等病理改变;与模型组比较,痛风立安胶囊高剂量组大鼠上述指标水平均显著降低
         (P<0.05),中、低剂量组大鼠上述大部分指标水平均显著降低(P<0.05),且大鼠踝关节滑膜增生改善、炎症细胞浸润减少。体外
          实验结果显示,痛风立安胶囊可显著降低细胞中NO、ROS、IL-1β水平和NF-κB蛋白表达水平(P<0.01),并抑制NF-κB入核。结
          论  痛风立安胶囊对痛风性关节炎具有较好的抗炎作用,其作用机制可能与抑制NF-κB信号通路活性有关。
          关键词  壮药;痛风立安胶囊;痛风性关节炎;抗炎作用;NF-κB信号通路

          Study  on  anti-inflammatory  effects  and  mechanism  of  Zhuang  medicine  Tongfeng  li’an  capsules  on  gouty
          arthritis
          ZHAO Xiangpei,DU Nana,LI Fengzhen,SHU Jianlong,LONG Chaoyang,ZOU Xiaosu,SUN Zongxi
         (Laboratory of Zhuang and Yao Medical Research, Guangxi International Zhuang Medicine Hospital Affiliated to
          Guangxi University of Chinese Medicine, Nanning 530201, China)

          ABSTRACT    OBJECTIVE  To  investigate  the  anti-inflammatory  effects  and  mechanism  of  Zhuang  medicine  Tongfeng  li’an
          capsules on gouty arthritis in combination with in vivo and in vitro experiments. METHODS Sixty rats were randomly divided into
          normal  group,  model  group,  positive  control  group (27  mg/kg  allopurinol+0.27  mg/kg  colchicine), Tongfeng  li’an  capsules  low-
          dose,  medium-dose  and  high-dose  groups (2.2,  4.5,  9.0  g/kg),  with  10  rats  in  each  group.  Except  for  normal  group,  gouty
          arthritis  model  of  rats  was  induced  in  other  groups.  Rats  in  each  administration  group  were  given  corresponding  drugs
          intragastrically, and rats in the normal group and model group were given equal volume of water intragastrically for 14 consecutive
          days. The  degree  of  ankle  joint  swelling,  serum  level  of  interleukin-1β (IL-1β)  and  protein  expressions  of  nuclear  factor  kappa-B
         (NF-κB)  in  synovial  tissue  were  detected,  and  the  histopathological  changes  of  synovium  tissue  in  the  ankle  joint  of  rats  were
          observed.  The  inflammation  model  was  established  by  stimulating  RAW264.7  cells  with  lipopolysaccharide.  After  Tongfeng  li’an
          capsules (62.5, 125, 250 μg/mL) were given, the levels of nitric oxide (NO), reactive oxygen species (ROS) and IL-1β in the
          cells and protein expression of NF-κB were detected, and NF-κB localization in the cells was also determined. RESULTS Results
          of  in  vivo  experiment  showed  that  compared  with  normal  group,  the  swelling  degree  of  the  ankle  joint,  serum  IL-1β  level  and
          protein  expression  of  NF-κB  in  synovium  tissue  were  all  increased  significantly  in  model  group (P<0.05);  pathological  changes
          such  as  synovial  hyperplasia,  edema,  vascular  congestion,  capillary  hyperplasia,  and  increased  inflammatory  cells  were  observed.
          Compared  with  model  group,  the  levels  of  above  indexes  were  all  decreased  significantly  in  Tongfeng  li’an  capsules  high-dose
                                                              group  (P<0.05),  and  most  of  the  above  indexes  were
              Δ 基金项目 国家中医药管理局“十二五”重点学科民族药学                    significantly  reduced  in  Tongfeng  li’an  capsules  medium-dose
         (壮药学)建设项目;广西中医药大学“高层次人才培育创新团队”                       and  low-dose  groups (P<0.05);  synovial  hyperplasia  of  the
          项目(No.2022A008);广西中医药大学博士科研启动基金项目(No.               ankle joint improved, and the infiltration of inflammatory cells
          2019BS044)
                                                              decreased. Results of in vitro experiment showed that Tongfeng
             *第一作者 副研究员,博士。研究方向:壮医药作用机制。E-
          mail:zhaoxiangpei@126.com                           li’an capsule could significantly reduce the levels of NO, ROS
              # 通信作者 高级工程师,博士。研究方向:医疗机构制剂开发及                  and  IL-1β  and  protein  expression  of  NF- κB(P<0.01),  and
          基础研究。E-mail:zongxisun@163.com                       inhibit  NF- κB  nucleation.  CONCLUSIONS  Tongfeng  li’an


          · 814 ·    China Pharmacy  2023 Vol. 34  No. 7                               中国药房  2023年第34卷第7期
   47   48   49   50   51   52   53   54   55   56   57